These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
102 related items for PubMed ID: 8782861
21. High content screen microscopy analysis of A beta 1-42-induced neurite outgrowth reduction in rat primary cortical neurons: neuroprotective effects of alpha 7 neuronal nicotinic acetylcholine receptor ligands. Hu M, Schurdak ME, Puttfarcken PS, El Kouhen R, Gopalakrishnan M, Li J. Brain Res; 2007 Jun 02; 1151():227-35. PubMed ID: 17449017 [Abstract] [Full Text] [Related]
22. Methyllycaconitine is a potent antagonist of alpha-conotoxin-MII-sensitive presynaptic nicotinic acetylcholine receptors in rat striatum. Mogg AJ, Whiteaker P, McIntosh JM, Marks M, Collins AC, Wonnacott S. J Pharmacol Exp Ther; 2002 Jul 02; 302(1):197-204. PubMed ID: 12065717 [Abstract] [Full Text] [Related]
23. Characterization of [3H]ABT-418: a novel cholinergic channel ligand. Anderson DJ, Williams M, Pauly JR, Raszkiewicz JL, Campbell JE, Rotert G, Surber B, Thomas SB, Wasicak J, Arneric SP. J Pharmacol Exp Ther; 1995 Jun 02; 273(3):1434-41. PubMed ID: 7791118 [Abstract] [Full Text] [Related]
24. Cognitive enhancing properties and tolerability of cholinergic agents in mice: a comparative study of nicotine, donepezil, and SIB-1553A, a subtype-selective ligand for nicotinic acetylcholine receptors. Bontempi B, Whelan KT, Risbrough VB, Lloyd GK, Menzaghi F. Neuropsychopharmacology; 2003 Jul 02; 28(7):1235-46. PubMed ID: 12700710 [Abstract] [Full Text] [Related]
25. Regulation of GABA release by nicotinic acetylcholine receptors in the neonatal rat hippocampus. Maggi L, Sher E, Cherubini E. J Physiol; 2001 Oct 01; 536(Pt 1):89-100. PubMed ID: 11579159 [Abstract] [Full Text] [Related]
26. Synthesis and nicotinic activity of epiboxidine: an isoxazole analogue of epibatidine. Badio B, Garraffo HM, Plummer CV, Padgett WL, Daly JW. Eur J Pharmacol; 1997 Feb 26; 321(2):189-94. PubMed ID: 9063687 [Abstract] [Full Text] [Related]
27. Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity. Kihara T, Shimohama S, Sawada H, Kimura J, Kume T, Kochiyama H, Maeda T, Akaike A. Ann Neurol; 1997 Aug 26; 42(2):159-63. PubMed ID: 9266724 [Abstract] [Full Text] [Related]
28. Neuroprotective effects of donepezil through inhibition of GSK-3 activity in amyloid-beta-induced neuronal cell death. Noh MY, Koh SH, Kim Y, Kim HY, Cho GW, Kim SH. J Neurochem; 2009 Mar 26; 108(5):1116-25. PubMed ID: 19077054 [Abstract] [Full Text] [Related]
29. A novel nicotinic mechanism underlies β-amyloid-induced neurotoxicity. Liu Q, Xie X, Emadi S, Sierks MR, Wu J. Neuropharmacology; 2015 Oct 26; 97():457-63. PubMed ID: 25959067 [Abstract] [Full Text] [Related]
30. An increase in intracellular free calcium ions by nicotinic acetylcholine receptors in a single cultured rat cortical astrocyte. Oikawa H, Nakamichi N, Kambe Y, Ogura M, Yoneda Y. J Neurosci Res; 2005 Feb 15; 79(4):535-44. PubMed ID: 15635597 [Abstract] [Full Text] [Related]
31. Mechanism of neuroprotection by donepezil pretreatment in rat cortical neurons chronically treated with donepezil. Takada-Takatori Y, Kume T, Ohgi Y, Izumi Y, Niidome T, Fujii T, Sugimoto H, Akaike A. J Neurosci Res; 2008 Dec 15; 86(16):3575-83. PubMed ID: 18655200 [Abstract] [Full Text] [Related]
32. Anxiolytic-like effects of the novel cholinergic channel activator ABT-418. Brioni JD, O'Neill AB, Kim DJ, Buckley MJ, Decker MW, Arneric SP. J Pharmacol Exp Ther; 1994 Oct 15; 271(1):353-61. PubMed ID: 7965735 [Abstract] [Full Text] [Related]
33. Evidence that nicotinic alpha(7) receptors are not involved in the hyperlocomotor and rewarding effects of nicotine. Grottick AJ, Trube G, Corrigall WA, Huwyler J, Malherbe P, Wyler R, Higgins GA. J Pharmacol Exp Ther; 2000 Sep 15; 294(3):1112-9. PubMed ID: 10945867 [Abstract] [Full Text] [Related]
34. Acetylcholine protection of adult pig retinal ganglion cells from glutamate-induced excitotoxicity. Wehrwein E, Thompson SA, Coulibaly SF, Linn DM, Linn CL. Invest Ophthalmol Vis Sci; 2004 May 15; 45(5):1531-43. PubMed ID: 15111612 [Abstract] [Full Text] [Related]
35. ABT-418: discriminative stimulus properties and effect on ventral tegmental cell activity. Brioni JD, Kim DJ, Brodie MS, Decker MW, Arneric SP. Psychopharmacology (Berl); 1995 Jun 15; 119(4):368-75. PubMed ID: 7480515 [Abstract] [Full Text] [Related]
36. Cholinergic channel activators: novel opportunities for the treatment of CNS disorders. Sullivan JP, Decker MW, Donnelly-Roberts D, Brioni JD, Bannon AW, Holladay MW, Anderson DJ, Briggs CA, Williams M, Arneric SP. Proc West Pharmacol Soc; 1995 Jun 15; 38():127-30. PubMed ID: 7480004 [Abstract] [Full Text] [Related]
37. In vitro pharmacological characterization of (+/-)-4-[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A), a nicotinic acetylcholine receptor ligand. Rao TS, Adams PB, Correa LD, Santori EM, Sacaan AI, Reid RT, Suto CM, Vernier JM. Brain Res; 2003 Aug 15; 981(1-2):85-98. PubMed ID: 12885429 [Abstract] [Full Text] [Related]
38. Nicotine-induced phosphorylation of ERK in mouse primary cortical neurons: evidence for involvement of glutamatergic signaling and CaMKII. Steiner RC, Heath CJ, Picciotto MR. J Neurochem; 2007 Oct 15; 103(2):666-78. PubMed ID: 17666046 [Abstract] [Full Text] [Related]
39. Pharmacological characterization of SIB-1765F: a novel cholinergic ion channel agonist. Sacaan AI, Reid RT, Santori EM, Adams P, Correa LD, Mahaffy LS, Bleicher L, Cosford ND, Stauderman KA, McDonald IA, Rao TS, Lloyd GK. J Pharmacol Exp Ther; 1997 Jan 15; 280(1):373-83. PubMed ID: 8996218 [Abstract] [Full Text] [Related]